Skip to main content

Not investment advice.Read full disclaimer

Healthcare · Biotechnology

52W Range

36thpctl

Volume

0.14×avg

Market Cap

8.54MUSD

P/E Ratio

-1.0TTM

Div Yield

-ann

Continue with finqOS

Get the full profile on Brainstorm Cell Therapeutics Inc.

Executive team, business description, key stats, and everything you need to understand the company.

Start Free Trial→Sign In

14-day free trial · No credit card required

Brainstorm Cell Therapeutics Inc.

BCLIOther OTC·USD·Closed

Brainstorm Cell Therapeutics Inc.

BCLIOther OTC·USD·Closed

$0.77

−2.47%

$0.77

−$0.02 (2.47%)

52W Range

36thpctl

Volume

0.14×avg

Mkt Cap

8.54MUSD

P/E

-1.0TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

BCLI: Brainstorm Cell Therapeutics Inc. Company Profile & Overview | finqOS